Reply to 'fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause requiring careful evaluation of the benefit-risk balance'.
Autor: | Roberts, Megan Z., Andrus, Miranda R. |
---|---|
Předmět: | |
Zdroj: | Expert Opinion on Pharmacotherapy; Oct2024, Vol. 25 Issue 14, p1973-1974, 2p |
Databáze: | Complementary Index |
Externí odkaz: |